Optician India

Abstract

The rapid rise of childhood myopia has transformed lens prescribing from a routine refractive task into a strategic public-health measure. Today’s advanced myopia-control optics—ranging from defocus-based spectacle lenses to orthokeratology and multifocal contact lenses—offer measurable reductions in progression, especially among children whose lifestyles are dominated by digital devices and limited outdoor exposure. With technology influencing both the cause and monitoring of myopia, the optometrist’s role extends beyond clinical correction, becoming an advocate for population-level eye health. Beyond visual clarity, contemporary lens options influence a child’s long-term ocular safety, comfort, confidence, and quality of life. As optometry increasingly embraces proactive myopia management, every lens decision becomes a contribution towards healthier vision futures.

The Modern Myopia Crisis

Recent projections indicate that half of the global population may be myopic by 2050 [1]. An obvious driver is the growing dependence on personal digital technology—smartphones, tablets, and online learning platforms. Continuous near-focus demands reduce blink rate, increase accommodative stress and encourage indoor lifestyles where sunlight exposure is inadequate. This shift underscores the need for optometrists to implement interventions capable of slowing myopic progression, not just correcting refractive error. Accurate assessment and access to effective lens technologies are critical components of modern myopia control.

Strong Outcomes from Modern Myopia-Control Lenses

Multiple studies confirm that slowing even a single diopter of myopia reduces the lifetime risk of vision-threatening ocular disease [2]. Evidence-based strategies that help limit progression in children include soft multifocal lenses, orthokeratology, low-dose atropine, newly developed spectacle designs, and peripheral defocus-based technologies [3].

Defocus-Incorporated Multiple Segment (DIMS) Lenses
DIMS spectacle lenses have demonstrated approximately 50% reduction in progression through controlled peripheral defocus [4]. Qualitative research highlights strong acceptance among parents, who prefer DIMS because they resemble regular single-vision lenses, are convenient to handle, and do not visibly appear as a “treatment lens” for children [5]. Children using DIMS have also reported better confidence due to slower prescription changes and reduced digital discomfort.

Orthokeratology (Ortho-K)
Ortho-K achieves temporary myopia correction by reshaping the cornea using specially designed, reverse-geometry rigid lenses worn overnight. The effect is mediated by central epithelial thinning and compensatory mid-peripheral thickening, creating optics that reduce both refractive error and axial elongation [6]. Clinical studies show that Ortho-K can slow axial growth by 30%–60% while offering spectacle-free daytime vision [7].

Spectacle Lenses with Highly Aspherical Lenslets (HAL)
HAL lenses use 11 rings of tiny aspherical lenslets to induce controlled myopic defocus in front of the retina. These lenses have demonstrated significant reduction in myopia progression through five-year follow-ups, making them a valuable option within the expanding spectacle-based control category [8].

Progressive Addition Lenses (PALs)
Although not as potent as newer designs, PALs benefit children exhibiting accommodative lag, near visual stress and digital eye strain—factors increasingly common due to extended screen use [9].

Together, these evolving lens technologies empower parents and optometrists to make informed choices that influence not only refractive outcomes, but also children’s ocular well-being and confidence.

When Lens Designs Lead to Unintended Outcomes

Rather than “bad results,” certain lens designs may produce unintended refractive effects. For instance, clinical evidence shows that some peripheral defocus spectacle lenses may increase astigmatism in certain patients, particularly due to biometrical changes associated with axial elongation [10]. Increased astigmatism not only reduces clarity but may also reduce the effectiveness of myopia-control strategies. These findings reinforce a critical point: technology alone is not enough—clinical precision and follow-up are essential.

Accuracy: The Invisible Foundation of Myopia Control

The effectiveness of the most advanced lens technology depends on fundamental dispensing principles—accurate centration, precise refractive measurements, correct pupil alignment, proper frame fitting, and consistent follow-ups. Mistakes in these areas can accelerate progression rather than slow it.

Partial Correction Isn’t a Strategy
Research clearly shows that intentional under-correction accelerates myopia, contradicting the misconception that partial correction slows progression [11]. Full, accurate correction remains a central principle of myopia-management practice.

Optical Control Depends on Fit and Alignment
For Ortho-K, improper centration or inadequate topography-based fitting can reduce treatment impact and increase risk [12]. Likewise, for multifocal contact lenses and advanced spectacle designs, even slight decentration or incorrect add power compromises treatment outcomes. Myopia control success, therefore, requires attention not only to lens type but its precise application and verification.

Pharmaceutical Options: A Growing Partnership

In many countries, optometrists now prescribe pharmacological myopia treatments such as low-dose atropine, either independently or collaboratively with ophthalmologists [13]. Studies support its ability to slow myopic progression and reduce the lifetime risk of complications such as myopic maculopathy and retinal detachment [14]. This combined optical-pharmaceutical strategy further expands the toolkit of modern myopia management.

Digital Innovation and AI in Myopia Care

Technology is not only contributing to the myopia epidemic—it is also helping predict and monitor it. Innovations such as AI models capable of forecasting five-year risk of high myopia using fundus imaging and clinical data hold major potential for early diagnosis and personalized care [15]. Smartphone apps that monitor screen time, cloud-based systems tracking axial growth, and digital lifestyle counseling tools are emerging as routine components of pediatric myopia programs.

Myopia Control as Public-Health Optometry

Today’s children live in a world of intense academic pressure and screen engagement; many experience visual stress long before developing high prescriptions. For parents, frequent prescription changes are worrying; for children, blurred vision can quietly erode confidence, school performance and quality of life. Myopia-control lenses offer not just treatment—they offer reassurance and stability.

Optometrists therefore play a vital public-health role: educating families on screen habits, encouraging outdoor activity, providing evidence-based counseling, and carefully tracking ocular growth. Their work shapes not only individual eyesight but the future visual health of entire communities.

References:

1. Bullimore, M. A., & Brennan, N. A. (2019). Myopia control: Why each diopter matters. Optometry and Vision Science, 96(6), 463–465.

2. Charm, J., & Cho, P. (2013). High myopia-partial reduction ortho-k: A 2-year randomized study. Optometry and Vision Science, 90(6), 530–539. https://doi.org/10.1097/OPX.0b013e318293657d

3. Esposito, C. A., Peterson, C., Coronado, C., Vasudevan, B., & Ciuffreda, K. J. (2012). Under-correction of myopia increases myopic progression—A retrospective study. Investigative Ophthalmology & Visual Science, 53(14), 4446.

4. Fatimah, M., Agarkar, S., & Narayanan, A. (2024). Impact of defocus incorporated multiple segments (DIMS) spectacle lenses for myopia control on quality of life of the children: A qualitative study. BMJ Open Ophthalmology, 9, e001562.

5. Foo, L. L., Lim, G. Y. S., Lanca, C., Wong, C. W., Hoang, Q. V., Zhang, X. J., ... & Ang, M. (2023). Deep learning system to predict the 5-year risk of high myopia using fundus imaging in children. NPJ Digital Medicine, 6(1), 10.

6. Fricke, T., Hurairah, H., Huang, Y., & Ho, S. M. (2019). Pharmacological interventions in myopia management. Community Eye Health, 32(105), 21–22.

7. Holden, B. A., Fricke, T. R., Wilson, D. A., Jong, M., Naidoo, K. S., Sankaridurg, P., ... & Resnikoff, S. (2016). Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology, 123(5), 1036–1042. https://doi.org/10.1016/j.ophtha.2016.01.006

8. Huang, J., Wen, D., Wang, Q., McAlinden, C., Flitcroft, I., Chen, H., ... & Qu, J. (2016). Efficacy comparison of 16 interventions for myopia control in children: A network meta-analysis. Ophthalmology, 123(4), 697–708.

9. Lam, C. S., Tang, W. C., Lee, P. H., Zhang, H. Y., Qi, H., Hasegawa, K., & To, C. H. (2022). Myopia control effect of defocus incorporated multiple segments (DIMS) spectacle lens in Chinese children: results of a 3-year follow-up study. British Journal of Ophthalmology, 106(8), 1110–1114. https://doi.org/10.1136/bjophthalmol-2020-317664

10. Lee, Y. C., Wang, J. H., & Chiu, C. J. (2017). Effect of orthokeratology on myopia progression: Twelve-year results of a retrospective cohort study. BMC Ophthalmology, 17, 243. https://doi.org/10.1186/s12886-017-0639-4

11. Li, X., Huang, Y., Liu, C., Chang, X., Cui, Z., Yang, Q., ... & Bao, J. (2025). Myopia control efficacy of spectacle lenses with highly aspherical lenslets: Results of a 5-year follow-up study. Eye and Vision, 12(1), 10. https://doi.org/10.1186/s40662-025-00427-3

12. Sartor, L., Hunter, D. S., Vo, M. L., & Samarawickrama, C. (2024). Benefits and risks of orthokeratology treatment: A systematic review and meta-analysis. International Ophthalmology, 44(1), 239. https://doi.org/10.1007/s10792-024-03175-w

13. Walline, J. J. (2016). Myopia control: A review. Eye & Contact Lens, 42(1), 3–8. https://doi.org/10.1097/ICL.0000000000000207

14. Xu, W., Li, X., Zhang, J., Li, H., Ding, X., Hu, X., Quan, X., Su, Y., Lu, F., & Chen, J. (2025). The peripheral defocus designed spectacle lenses might increase astigmatism in myopic children. Translational Vision Science & Technology, 14(3), 8. https://doi.org/10.1167/tvst.14.3.8

15. Yap, T. P., & Mishu, M. P. (2024). Pharmaceutical prescribing privileges for optometrists to combat childhood myopia in Singapore: Public health policy review and analysis. Children, 11(12), 1548. https://doi.org/10.3390/children11121548